Related Experiment Videos
Summary
Treatment-resistant depression can be managed with various advanced therapies. Infusion therapies, including mono-infusion and combined infusion, are effective for severe cases, with specific options for masked depression and geriatric depression.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Most depression cases are treatable on an outpatient basis.
- 15-20% of patients require hospitalization due to therapy-resistant depression.
Purpose of the Study:
- To outline treatment strategies for therapy-resistant depression.
- To detail specific interventions for different subtypes of treatment-resistant depression.
Main Methods:
- Mono-infusion therapy for endogenous and psychogenic depressions.
- Combined infusion therapy with relaxation and neuroleptics for intractable cases.
- Maprotiline infusions for masked depression with anxiety.
- Infusion therapy with MAO inhibitors for involutional/geriatric depression.
Main Results:
- Mono-infusion is effective for therapy-resistant endogenous and psychogenic depressions.
- Maprotiline infusions offer mood-brightening and anxiolytic effects for masked depression.
- Combination therapies and electroconvulsive therapy (ECT) are reserved for rare, severe, or treatment-refractory cases.
Conclusions:
- A range of specialized treatments exist for therapy-resistant depression.
- Treatment selection depends on the specific depression subtype and patient presentation.
- Advanced therapies like infusions and, cautiously, ECT, can manage severe and intractable depression.